Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE4.1100
- TODAY'S CHANGE (%)-0.0300 (-0.7246%)
- Bid / Lots4.0400/ 6
- Ask / Lots4.2500/ 2
- Open / Previous Close4.1600 / 4.1400
- Day Range
- 52 Week Range
- Volume593,870
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 2849 | 4.11 |
| 09:34 ET | 11280 | 4.11 |
| 09:36 ET | 380 | 4.13 |
| 09:38 ET | 100 | 4.09 |
| 09:39 ET | 301 | 4.135 |
| 09:41 ET | 100 | 4.1252 |
| 09:43 ET | 1300 | 4.135 |
| 09:48 ET | 100 | 4.14 |
| 09:50 ET | 1769 | 4.16 |
| 09:52 ET | 1850 | 4.195 |
| 09:54 ET | 1200 | 4.195 |
| 09:56 ET | 3275 | 4.1899 |
| 09:57 ET | 2171 | 4.185 |
| 09:59 ET | 400 | 4.17 |
| 10:01 ET | 6807 | 4.185 |
| 10:03 ET | 4473 | 4.17 |
| 10:06 ET | 800 | 4.16 |
| 10:08 ET | 2400 | 4.165 |
| 10:10 ET | 5428 | 4.155 |
| 10:12 ET | 100 | 4.15 |
| 10:14 ET | 515 | 4.155 |
| 10:15 ET | 985 | 4.155 |
| 10:17 ET | 400 | 4.14 |
| 10:19 ET | 600 | 4.145 |
| 10:21 ET | 1400 | 4.155 |
| 10:24 ET | 100 | 4.155 |
| 10:26 ET | 3500 | 4.155 |
| 10:28 ET | 5125 | 4.15 |
| 10:30 ET | 963 | 4.145 |
| 10:33 ET | 6200 | 4.145 |
| 10:35 ET | 4056 | 4.17 |
| 10:37 ET | 2412 | 4.17 |
| 10:39 ET | 3995 | 4.1667 |
| 10:46 ET | 400 | 4.16 |
| 10:50 ET | 2090 | 4.17 |
| 10:51 ET | 1200 | 4.19 |
| 10:53 ET | 200 | 4.18 |
| 10:55 ET | 200 | 4.17 |
| 10:57 ET | 100 | 4.1694 |
| 11:00 ET | 200 | 4.16 |
| 11:02 ET | 2195 | 4.18 |
| 11:06 ET | 895 | 4.185 |
| 11:08 ET | 400 | 4.182 |
| 11:09 ET | 250 | 4.182 |
| 11:11 ET | 300 | 4.175 |
| 11:15 ET | 200 | 4.18 |
| 11:18 ET | 300 | 4.18 |
| 11:22 ET | 400 | 4.19 |
| 11:24 ET | 300 | 4.1942 |
| 11:26 ET | 6654 | 4.19 |
| 11:27 ET | 8722 | 4.195 |
| 11:29 ET | 200 | 4.185 |
| 11:31 ET | 400 | 4.185 |
| 11:33 ET | 500 | 4.18 |
| 11:36 ET | 3200 | 4.16 |
| 11:38 ET | 100 | 4.15 |
| 11:40 ET | 363 | 4.14 |
| 11:44 ET | 4416 | 4.125 |
| 11:45 ET | 218 | 4.125 |
| 11:49 ET | 391 | 4.12 |
| 11:51 ET | 200 | 4.11 |
| 11:56 ET | 2056 | 4.1093 |
| 11:58 ET | 200 | 4.105 |
| 12:00 ET | 118 | 4.105 |
| 12:02 ET | 12158 | 4.105 |
| 12:03 ET | 2263 | 4.105 |
| 12:05 ET | 339 | 4.095 |
| 12:07 ET | 6654 | 4.1 |
| 12:09 ET | 2434 | 4.1093 |
| 12:14 ET | 918 | 4.11 |
| 12:16 ET | 100 | 4.11 |
| 12:18 ET | 200 | 4.11 |
| 12:20 ET | 118 | 4.115 |
| 12:23 ET | 710 | 4.12 |
| 12:25 ET | 100 | 4.12 |
| 12:27 ET | 300 | 4.1199 |
| 12:30 ET | 200 | 4.12 |
| 12:32 ET | 100 | 4.12 |
| 12:34 ET | 100 | 4.125 |
| 12:36 ET | 400 | 4.125 |
| 12:38 ET | 318 | 4.125 |
| 12:41 ET | 1331 | 4.12 |
| 12:43 ET | 114 | 4.125 |
| 12:45 ET | 38215 | 4.1101 |
| 12:48 ET | 3535 | 4.095 |
| 12:50 ET | 100 | 4.095 |
| 12:52 ET | 1200 | 4.09 |
| 12:54 ET | 9722 | 4.09 |
| 12:56 ET | 100 | 4.09 |
| 12:57 ET | 3100 | 4.095 |
| 01:01 ET | 454 | 4.07 |
| 01:03 ET | 2000 | 4.075 |
| 01:06 ET | 3125 | 4.065 |
| 01:08 ET | 118 | 4.065 |
| 01:10 ET | 1594 | 4.08 |
| 01:12 ET | 2312 | 4.075 |
| 01:14 ET | 300 | 4.079 |
| 01:15 ET | 3200 | 4.0788 |
| 01:17 ET | 2100 | 4.065 |
| 01:19 ET | 5225 | 4.07 |
| 01:21 ET | 1400 | 4.07 |
| 01:24 ET | 4200 | 4.065 |
| 01:26 ET | 12751 | 4.06 |
| 01:28 ET | 3766 | 4.07 |
| 01:30 ET | 1577 | 4.05 |
| 01:32 ET | 5218 | 4.055 |
| 01:33 ET | 12415 | 4.055 |
| 01:37 ET | 5100 | 4.055 |
| 01:39 ET | 5000 | 4.055 |
| 01:42 ET | 10463 | 4.0543 |
| 01:44 ET | 14861 | 4.04 |
| 01:46 ET | 110 | 4.0387 |
| 01:48 ET | 14181 | 4.03 |
| 01:50 ET | 100 | 4.03 |
| 01:51 ET | 676 | 4.0291 |
| 01:53 ET | 7101 | 4.015 |
| 01:55 ET | 5870 | 4.04 |
| 01:57 ET | 5200 | 4.045 |
| 02:00 ET | 5600 | 4.05 |
| 02:02 ET | 6700 | 4.0443 |
| 02:04 ET | 500 | 4.045 |
| 02:08 ET | 2236 | 4.05 |
| 02:13 ET | 1400 | 4.04 |
| 02:15 ET | 17904 | 4.025 |
| 02:22 ET | 2449 | 4.012 |
| 02:24 ET | 2822 | 4.005 |
| 02:26 ET | 800 | 4.0092 |
| 02:27 ET | 325 | 4.01 |
| 02:29 ET | 4445 | 4.0007 |
| 02:31 ET | 100 | 4 |
| 02:33 ET | 3600 | 4.0099 |
| 02:36 ET | 3600 | 4.035 |
| 02:38 ET | 3955 | 4.045 |
| 02:40 ET | 5251 | 4.05 |
| 02:42 ET | 2438 | 4.05 |
| 02:44 ET | 2298 | 4.05 |
| 02:45 ET | 3092 | 4.055 |
| 02:47 ET | 15155 | 4.075 |
| 02:49 ET | 700 | 4.075 |
| 02:51 ET | 300 | 4.075 |
| 02:54 ET | 732 | 4.075 |
| 02:56 ET | 400 | 4.075 |
| 02:58 ET | 1500 | 4.075 |
| 03:00 ET | 2200 | 4.065 |
| 03:02 ET | 2200 | 4.065 |
| 03:03 ET | 2800 | 4.065 |
| 03:05 ET | 6311 | 4.06 |
| 03:07 ET | 600 | 4.065 |
| 03:12 ET | 100 | 4.065 |
| 03:14 ET | 5720 | 4.04 |
| 03:16 ET | 1691 | 4.055 |
| 03:20 ET | 16101 | 4.065 |
| 03:21 ET | 1600 | 4.065 |
| 03:23 ET | 1700 | 4.065 |
| 03:25 ET | 2100 | 4.06 |
| 03:27 ET | 1500 | 4.07 |
| 03:30 ET | 200 | 4.07 |
| 03:32 ET | 6700 | 4.075 |
| 03:34 ET | 2598 | 4.065 |
| 03:39 ET | 300 | 4.065 |
| 03:41 ET | 400 | 4.065 |
| 03:43 ET | 10833 | 4.075 |
| 03:45 ET | 500 | 4.075 |
| 03:48 ET | 5724 | 4.095 |
| 03:50 ET | 10953 | 4.085 |
| 03:52 ET | 3393 | 4.08 |
| 03:54 ET | 629 | 4.085 |
| 03:56 ET | 2340 | 4.085 |
| 03:57 ET | 4006 | 4.1 |
| 03:59 ET | 29658 | 4.11 |
Sep 17, 2024
DJ Mereo BioPharma Group Down Over 9%, on Pace for Largest Percent Decrease Since August 2023 -- Data Talk, from 1:42PM ET on Tuesday Sep 17, 2024 by Dow Jones
1:42PM ET on Tuesday Sep 17, 2024 by Dow Jones
Sep 16, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 12:21PM ET on Monday Sep 16, 2024 by Dow Jones
12:21PM ET on Monday Sep 16, 2024 by Dow Jones
Sep 12, 2024
Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference, from 5:35PM ET on Thursday Sep 12, 2024 by Dow Jones
5:35PM ET on Thursday Sep 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 658.5M | -12.4x | --- |
Arbutus Biopharma Corp | 843.9M | -8.7x | --- |
4D Molecular Therapeutics Inc | 844.5M | -4.9x | --- |
Immunome Inc | 959.1M | -2.6x | --- |
Perspective Therapeutics Inc | 884.7M | -9.6x | --- |
Dianthus Therapeutics Inc | 850.1M | -4.9x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). In addition to the rare disease programs, it has two oncology product candidates in clinical development. Etigilimab is an IgG1 monoclonal antibody which binds to the human T-cell immunoreceptor with Ig and ITIM domains (TIGIT) receptor on immune cells to improve the activation and effectiveness of T-cell and NK cell antitumor activity. Navicixizumab is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Navicixizumab is developed for the treatment of late line ovarian cancer.
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $658.5M |
|---|---|
Revenue (TTM) | $10.6M |
Shares Outstanding | 153.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.97 |
EPS | $-0.33 |
Book Value | $0.47 |
P/E Ratio | -12.4x |
Price/Sales (TTM) | 62.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
